SCHEMBL25491998

SCHEMBL25491998

COC(=O)C[C@H](NC(C)=O)C(=O)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 5/20 0.59
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA3 P07451 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA5A P35218 1/20 0.53
CA7 P43166 1/20 0.53
CACNA1C Q13936 1/20 0.53
SCN9A Q15858 1/20 0.53
CA9 Q16790 1/20 0.53
CA13 Q8N1Q1 1/20 0.53
CA14 Q9ULX7 1/20 0.53
CA5B Q9Y2D0 1/20 0.53
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 1/20 0.49
ABCB1 P08183 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25491992 1.00 TACR1 (0.59) TACR1CA12CA1CA2CA3
SCHEMBL30621976 0.88 TACR1 (0.61) TACR1CA12CA1CA2CA3
SCHEMBL27895749 0.88 TACR1 (0.61) TACR1CA12CA1CA2CA3
SCHEMBL28750936 0.88 TACR1 (0.61) TACR1CA12CA1CA2CA3
SCHEMBL6507631 0.86 MMP9 (0.50) TACR1ALDH1A1ABCB1MMP9REN
SCHEMBL25492010 0.86 ABCB1 (0.47) TACR1ALDH1A1KMT2AABCB1ALOX15
SCHEMBL31276678 0.85 ABCB1 (0.51) TACR1ALDH1A1KMT2AABCB1ALOX15
SCHEMBL5673271 0.84 TACR1 (0.53) TACR1CA12CA1CA2CA3
SCHEMBL27895748 0.84 TACR1 (0.53) TACR1CA12CA1CA2CA3
SCHEMBL25492090 0.84 MMP9 (0.48) ALDH1A1ABCB1MMP9REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023083291-A1 DERIVATIVE OF ASPARTIC ACID AND USE THEREOF IN TREATMENT OF METABOLIC DISEASES SUCH AS HEPATIC FIBROSIS AND NON-ALCOHOLIC HEPATITIS 深圳利沃生物医药科技有限公司 2023-05-19 WO disclosed